A

Actinogen Medical
ACW

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$73.07M
EV
A$50.50M
Shares Outstanding
3.18B
Beta
1.04

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
10.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Actinogen Medical Limited

gainify

A

Actinogen Medical Limited

ACW

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11β-HSD1 enzyme, which is in Ph...

Sector

Healthcare

Industry

Biotechnology

CEO

Gourlay, Steven

Employees

6

IPO Date

2007-10-16

Headquarters

109 Pitt Street, Suite 901, Level 9, Sydney, New South Wales, 2000, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.